Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
暂无分享,去创建一个
U. Rothlisberger | G. Davey | P. Dyson | M. Groessl | P. Campomanes | W. Ang | P. Dröge | C. Davey | Haojie Yu | A. Nazarov | Catherine M. Clavel | Charmian Hui Fang Yeo | Z. Adhireksan